تقرير تحليل حجم السوق العالمية لعدوى الخميرة وحصتها واتجاهاتها – نظرة عامة على الصناعة وتوقعاتها حتى عام 2031

تحليل سوق عدوى الخميرة

من المتوقع أن يؤدي ارتفاع حالات الإصابة بعدوى الخميرة إلى دفع نمو السوق في جميع أنحاء العالم. وفقًا لدراسات NCBI، في عام 2018، أصيبت حوالي 30٪ -50٪ من النساء بداء المبيضات المهبلية مرة واحدة على الأقل في حياتهن. علاوة على ذلك، في منطقة آسيا والمحيط الهادئ، تعد أنواع المبيضات أكثر أنواع عدوى الخميرة شيوعًا. وبالتالي، من المتوقع أن يُظهر السوق نموًا كبيرًا خلال الفترة المتوقعة.

حجم سوق عدوى الخميرة

تم تقييم حجم سوق عدوى الخميرة العالمية بنحو 4.37 مليار دولار أمريكي في عام 2023 ومن المتوقع أن يصل إلى 7.01 مليار دولار أمريكي بحلول عام 2031، بمعدل نمو سنوي مركب قدره 6.10٪ خلال الفترة المتوقعة من 2024 إلى 2031.

نطاق التقرير وتقسيم السوق       

تعريف سوق عدوى الخميرة

Candidiasis, often known as yeast or fungus infection, is a parasitic ailment. It's a naturally occurring component in the human body. It can cause infection in some cases due to changes in the body's immune level. It can also affect the skin, mouth, and stomach. Yeast infection in the vaginal area is very prevalent among women. Rashes, swelling, redness, stinging, and burning are all symptoms of this infection. Yeast infection can be caused by a lack of immunity, poor cleanliness, or lifestyle disorders.

Yeast infection Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Prevalence Of Diseases, Infections And Other Ailments

The factors such as the rise in the prevalence of autoimmune disease and yeast infection along with the development of new fungal infections is the most significant factor driving the growth for this market. The rise in the burden of ailments like the cardiovascular, gastrointestinal and other diseases are also expected to accelerate the overall growth of the market.

Furthermore, the improving economic conditions worldwide that enables access to the quality and improved healthcare are also expected to fuel market growth. Moreover, the rising awareness among the patients regarding the yeast infections also cushions the market’s growth within the forecasted period. The rising demand for antifungal drugs and government support for research and development are also projected to bolster the growth of the market.

Opportunities

• Growing Investments and Advancements

Moreover, the financing for the administration of research and development in medical science combined with introduction of new treatment options for yeast infections are estimated to generate lucrative opportunities for the market. The investments in this region for the yeast infection market will further offer numerous growth opportunities for the market.

Restraints/Challenges

• Issues Associated with Treatment

On the other hand, issues during treatments and various treatment-related side effects are expected to obstruct market growth.

• Other Limitations

Also, the concerning issues related to the drug resistance for the disorder and the incidents of unmet clinical needs are projected to challenge the yeast infection market in the forecast period of 2024-2031.

This yeast infection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the yeast infection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Yeast infection Market

Healthcare industry was largely impacted by the outbreak of COVID-19 as financial load on the healthcare industry was enormous. The yeast infection market was largely negatively impacted by the outbreak of COVID-19.  The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, medicine development and production, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, led to limited industry expansion and financial volatility.

Moreover, the treatment for the yeast infection is hampered. The majority of the doctors are assigned for COVID patient care, according to an orthopedic medical magazine. The clinical drug market, on the other hand, is seeing an increase in research that will lead to various innovations, which will have a positive impact on the market for yeast infections. After COVID-19, the yeast infection market will have a diverse product offering. The market for vaginal yeast infections will increase at the fastest rate.

Yeast infection Market Scope

The yeast infection market is segmented on the basis of pathogens, types, treatment and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Pathogens

• Candida Albicans
• Candida Glabrata
• Candida Rugosa
• Others

On the basis of pathogens, the yeast infection market is segmented into candida albicans, candida glabrata, candida rugosa and others.

Types

• Vaginal Yeast Infection
• Skin Yeast Infection
• Throat Yeast Infection
• Others

On the basis of types, the yeast infection market is segmented into vaginal yeast infection, skin yeast infection, throat yeast infection and others.

Treatment

• Medical Treatment
• Surgery

On the basis of treatment, the yeast infection market is bifurcated into medical treatment and surgery.

End User

• Hospital
• Clinics
• Ambulatory Centers
• Others

On the basis of end user, the yeast infection market is segmented into hospital, clinics, ambulatory centers, others.

Yeast infection Market Regional Analysis

The yeast infection market is analyzed and market size insights and trends are provided by country, pathogens, types, treatment and end user as referenced above.

The countries covered in the yeast infection market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the yeast infection market because of the increase in the in yeast infection. Moreover, the rise in the number of cases of vaginal infections within the region.

Europe is expected to witness significant growth during the forecast period of 2024 to 2031 due to the high prevalence of yeast infection within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The yeast infection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yeast infection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yeast infection market. The data is available for historic period 2010-2020.

Yeast infection Market Share

يوفر المشهد التنافسي لسوق عدوى الخميرة تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق عدوى الخميرة.

الشركات الرائدة في سوق عدوى الخميرة العاملة في السوق هي:

• شركة ساينكسيس المحدودة، (الولايات المتحدة)
• شركة ميرك وشركاه المحدودة (الولايات المتحدة)
• شركة باير ايه جي (ألمانيا)
• شركة أستيلاس فارما المحدودة (اليابان)
• شركة ثيرمو فيشر العلمية المحدودة، (الولايات المتحدة)
• نوفارتيس أيه جي (سويسرا)
• أبوت (الولايات المتحدة)
• شركة كاتالنت، (الولايات المتحدة)
• بيوميريوكس (فرنسا)
• شركة فايزر (الولايات المتحدة)
• شركة AbbVie Inc.، (الولايات المتحدة)
• أليرجان (أيرلندا)
• شركة جوبيلانت فارموفا المحدودة (الهند)
• سانوفي (فرنسا)
• أسترازينيكا (المملكة المتحدة)
• بروكر (الولايات المتحدة)
• مختبرات بروندافان المحدودة (الهند)
• شركة كوريا العالمية (الولايات المتحدة)
• كوردن فارما (ألمانيا)

أحدث التطورات في سوق عدوى الخميرة

• في ديسمبر 2021، نشرت Cidara Therapeutics, Inc. وMundipharma بيانات أولية إيجابية من التجربة السريرية الرئيسية ReSTORE Phase 3، والتي نظرت في فعالية وأمان ريزافونغين، وهو مرشح مضاد للفطريات مرة واحدة أسبوعياً، كعلاج من الخط الأول لمرض داء المبيضات وداء المبيضات الغازي.

SKU-13298